A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease which continues to carry an unacceptably high mortality and morbidity. The nitric oxide (NO) pathway has been implicated in the pathophysiology and progression of the disease. Its extremely short half-life and systemic effect...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cardiovasc Transl Res
Hoofdauteurs: Mohamed, Nura A., Ahmetaj-Shala, Blerina, Duluc, Lucie, Mackenzie, Louise S., Kirkby, Nicholas S., Reed, Daniel M., Lickiss, Paul D., Davies, Robert P., Freeman, Gemma R., Wojciak-Stothard, Beata, Chester, Adrian H., El-Sherbiny, Ibrahim M., Mitchell, Jane A., Yacoub, Magdi H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2016
Onderwerpen:
Correspondence
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4830862/
https://ncbi.nlm.nih.gov/pubmed/26960567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-016-9684-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items